Q2 EPS Estimates for HealthEquity Boosted by Zacks Research

Key Points

• Zacks Research raised its Q2 2027 earnings per share estimate for HealthEquity from $0.94 to $1.00, reflecting positive sentiment about the company’s performance.
• Several brokerages have updated their price targets for HealthEquity, with Royal Bank of Canada raising theirs to $110 and Jefferies Financial Group increasing it to $134.
• Institutional investors continue to show strong interest, with Farther Finance Advisors increasing its stake by 232.4% in the second quarter.

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Investment analysts at Zacks Research boosted their Q2 2027 earnings per share estimates for shares of HealthEquity in a note issued to investors on Tuesday, September 23rd. Zacks Research analyst Team now forecasts that the company will earn $1.00 per share for the quarter, up from their previous forecast of $0.94. The consensus estimate for HealthEquity's current full-year earnings is $2.32 per share. Zacks Research also issued estimates for HealthEquity's Q4 2027 earnings at $0.93 EPS.

Several other brokerages have also commented on HQY. Royal Bank Of Canada raised their price target on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. JMP Securities upped their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Jefferies Financial Group upped their target price on HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research report on Wednesday, September 3rd. JPMorgan Chase & Co. raised their price target on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 3rd. Finally, The Goldman Sachs Group upped their target price on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $119.77.

HealthEquity Stock Up 0.4%

Shares of NASDAQ HQY opened at $94.26 on Thursday. The stock has a 50 day moving average price of $92.71 and a 200 day moving average price of $93.91. The firm has a market capitalization of $8.12 billion, a price-to-earnings ratio of 57.13, a PEG ratio of 1.35 and a beta of 0.50. HealthEquity has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This trade represents a 3.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the company's stock in a transaction on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president owned 79,456 shares of the company's stock, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of HQY. Farther Finance Advisors LLC boosted its holdings in shares of HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company's stock valued at $26,000 after acquiring an additional 172 shares in the last quarter. Versant Capital Management Inc acquired a new stake in HealthEquity in the first quarter valued at about $28,000. WPG Advisers LLC purchased a new stake in HealthEquity in the 1st quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new position in HealthEquity during the 2nd quarter worth approximately $33,000. Finally, Cullen Frost Bankers Inc. raised its stake in shares of HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company's stock worth $37,000 after buying an additional 224 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.